The differences in blood glucose management and affects on cardiac function of SGLT2 and DPP4 inhibitors
Not Applicable
- Conditions
- Diabetes mellitus (DM) patients complicated with heart failure preserved ejection fraction (HFpEF)
- Registration Number
- JPRN-UMIN000032272
- Lead Sponsor
- Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy, breast-feeding, patients who may be pregnant, and patients who want pregnancy during the examination Patients who may be thought to worse blood glucose management with the protocol of this examination. Patients who are received with DPP 4 inhibitor, once a week. Patients with moderate or severe renal impairment (less than eGFR 45) Patients with severe hepatic impairment (Child-Pugh classification C) Patients who were judged inappropriate as subjects of this examination by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of total/cardiovascular death, re-hospitalization of HF and worsening of DM
- Secondary Outcome Measures
Name Time Method